{"id":"https://openalex.org/W4200436100","doi":"https://doi.org/10.3389/fimmu.2021.823576","title":"Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention","display_name":"Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention","publication_year":2021,"publication_date":"2021-12-21","ids":{"openalex":"https://openalex.org/W4200436100","doi":"https://doi.org/10.3389/fimmu.2021.823576","pmid":"https://pubmed.ncbi.nlm.nih.gov/34992615","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8724241"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2021.823576","doi":"https://doi.org/10.3389/fimmu.2021.823576","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.823576","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.823576/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.823576/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090001717","display_name":"Kshitij Wagh","orcid":"https://orcid.org/0000-0001-7552-6582","observed_orcids":["https://orcid.org/0000-0001-7552-6582"]},"institutions":[{"id":"https://openalex.org/I1343871089","display_name":"Los Alamos National Laboratory","ror":"https://ror.org/01e41cf67","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I1343871089","https://openalex.org/I198811213","https://openalex.org/I4210120050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kshitij Wagh","raw_affiliation_strings":["Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, United States","institution_ids":["https://openalex.org/I1343871089"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017311188","display_name":"Marit J. van Gils","orcid":"https://orcid.org/0000-0003-3422-8161","observed_orcids":["https://orcid.org/0000-0003-3422-8161"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marit J. van Gils","raw_affiliation_strings":["Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045240127","display_name":"Harry B. Gristick","orcid":"https://orcid.org/0000-0002-1957-2821","observed_orcids":["https://orcid.org/0000-0002-1957-2821"]},"institutions":[{"id":"https://openalex.org/I122411786","display_name":"California Institute of Technology","ror":"https://ror.org/05dxps055","country_code":"US","type":"education","lineage":["https://openalex.org/I122411786"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harry Gristick","raw_affiliation_strings":["Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, United States","institution_ids":["https://openalex.org/I122411786"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017579565","display_name":"Philipp Schommers","orcid":"https://orcid.org/0000-0003-3375-6800","observed_orcids":["https://orcid.org/0000-0003-3375-6800"]},"institutions":[{"id":"https://openalex.org/I180923762","display_name":"University of Cologne","ror":"https://ror.org/00rcxh774","country_code":"DE","type":"education","lineage":["https://openalex.org/I180923762"]},{"id":"https://openalex.org/I4210115305","display_name":"German Center for Infection Research","ror":"https://ror.org/028s4q594","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210115305","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I4210153755","display_name":"University Hospital Cologne","ror":"https://ror.org/05mxhda18","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210153755"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Philipp Schommers","raw_affiliation_strings":["Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany","German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany","Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I180923762","https://openalex.org/I4210153755"]},{"raw_affiliation_string":"German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I4210115305"]},{"raw_affiliation_string":"Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I180923762","https://openalex.org/I4210153755"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5017579565"],"corresponding_institution_ids":["https://openalex.org/I180923762","https://openalex.org/I4210115305","https://openalex.org/I4210153755"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":null,"first_page":"823576","last_page":"823576"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/broadly-neutralizing-antibodies","display_name":"broadly neutralizing antibodies","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hiv-1-prevention","display_name":"HIV-1 prevention","score":0.7749999761581421},{"id":"https://openalex.org/keywords/hiv-1-treatment","display_name":"HIV-1 treatment","score":0.925000011920929},{"id":"https://openalex.org/keywords/passive-immunization","display_name":"passive immunization","score":0.847000002861023},{"id":"https://openalex.org/keywords/viral-immune-evasion","display_name":"viral immune evasion","score":0.6100000143051147},{"id":"https://openalex.org/keywords/cd4-binding-site","display_name":"CD4 binding site","score":0.7400000095367432},{"id":"https://openalex.org/keywords/v1v2-loop","display_name":"V1V2 loop","score":0.8479999899864197},{"id":"https://openalex.org/keywords/membrane-proximal-external-region","display_name":"membrane-proximal external region","score":0.9440000057220459},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.7087014317512512},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5887064933776855},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5853585600852966},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4675983786582947},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.4471851587295532},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4122644066810608}],"mesh":[{"descriptor_ui":"D000080908","descriptor_name":"Broadly Neutralizing Antibodies","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":8,"locations":[{"id":"doi:10.3389/fimmu.2021.823576","doi":"https://doi.org/10.3389/fimmu.2021.823576","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.823576","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.823576/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8724241","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8724241","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:34992615","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34992615","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Editorial"},{"id":"pmh:oai:USBKOELN.ub.uni-koeln.de:59257","doi":null,"is_oa":false,"landing_page_url":"https://kups.ub.uni-koeln.de/59257/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400371","display_name":"K\u00f6lner Universit\u00e4ts PublikationsServer (Universit\u00e4t zu K\u00f6ln)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210115942","host_organization_name":"Rhenish Institute for Environmental Research","host_organization_lineage":["https://openalex.org/I4210115942"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"doc-type:article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/e39daa2f-c49a-409f-a9cb-eda082395dcf","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/e39daa2f-c49a-409f-a9cb-eda082395dcf","pdf_url":"https://pure.amsterdamumc.nl/files/150639195/Editorial.pdf","source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Wagh, K, van Gils, M J, Gristick, H & Schommers, P 2021, 'Editorial : Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention', Frontiers in immunology, vol. 12, 823576. https://doi.org/10.3389/fimmu.2021.823576","raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"pmh:oai:authors.library.caltech.edu:113037","doi":null,"is_oa":true,"landing_page_url":"https://authors.library.caltech.edu/113037/","pdf_url":null,"source":{"id":"https://openalex.org/S4306402161","display_name":"CaltechAUTHORS (California Institute of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I122411786","host_organization_name":"California Institute of Technology","host_organization_lineage":["https://openalex.org/I122411786"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/997a257e-1a93-409d-b846-b5675cb7a0fd","doi":null,"is_oa":true,"landing_page_url":"https://pure.amc.nl/en/publications/editorial(997a257e-1a93-409d-b846-b5675cb7a0fd).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in immunology, 12:823576. Frontiers Media S.A.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:2bbd68142b2846e5a8cc98b6fff93e8c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2bbd68142b2846e5a8cc98b6fff93e8c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 12 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2021.823576","doi":"https://doi.org/10.3389/fimmu.2021.823576","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.823576","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.823576/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7807330887","display_name":"Duke University - to facilitate the discovery of a safe, effective and practical HIV-1 vaccine by using valid laboratory criteria and Good Clinical Laboratory Practi...","funder_award_id":"OPP1032144","funder_id":"https://openalex.org/F4320306137","funder_display_name":"Bill and Melinda Gates Foundation"}],"funders":[{"id":"https://openalex.org/F4320306137","display_name":"Bill and Melinda Gates Foundation","ror":"https://ror.org/0456r8d26"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200436100.pdf","grobid_xml":"https://content.openalex.org/works/W4200436100.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399361534","https://openalex.org/W2803099968","https://openalex.org/W3156363049","https://openalex.org/W4221005715","https://openalex.org/W2989657937","https://openalex.org/W3165101569","https://openalex.org/W2901174889","https://openalex.org/W2530476528","https://openalex.org/W4400433101","https://openalex.org/W3186505124"],"abstract_inverted_index":{"Despite":[0],"the":[1,15,18,25,30,38,65,90,95,99,103,106,108,113,117,121,198,218,302],"success":[2],"of":[3,20,27,68,89,127,143,194,200,304,315],"antiretroviral":[4,144],"therapy":[5,145],"(ART)":[6,146],"in":[7,147,158,174,210,251,255],"suppressing":[8],"HIV-1":[9,42,78,96,188,215,249,259,266],"replication":[10],"and":[11,24,120,137,161,190,204,238,262,297,306,313],"preventing":[12],"disease":[13],"progression,":[14],"high":[16,82],"costs,":[17],"burden":[19],"daily":[21],"medication,":[22],"toxicity":[23],"development":[26],"resistance":[28,209],"underscore":[29],"need":[31],"for":[32,87,168,186,242,248,263,311],"new":[33,295],"therapeutic":[34],"approaches.":[35],"\\n":[36,285],"\\nOver":[37],"past":[39],"decade,":[40],"broadly":[41,70],"neutralizing":[43,71],"antibodies":[44,58],"(bNAbs)":[45],"were":[46],"discovered":[47],"that":[48,74,230,300],"are":[49,166,176],"up":[50],"to":[51,133,155,257,292],"a":[52,81,182],"1000-fold":[53],"more":[54,236],"potent":[55,237],"than":[56],"HIV-1-reactive":[57],"previously":[59],"described.":[60],"About":[61],"10":[62],"years":[63],"after":[64,141],"first":[66],"identification":[67],"these":[69,128],"antibodies,":[72,273],"bNAbs":[73,129,151,165,180,196,305],"effectively":[75],"target":[76],"multiple":[77],"variants":[79],"with":[80,116],"potency":[83],"have":[84,130,152],"been":[85,131,153],"found":[86],"most":[88],"immunological":[91],"important":[92],"epitopes":[93],"on":[94],"envelope-trimer":[97],"like":[98,279],"CD4":[100],"binding":[101],"site,":[102],"V1/V2":[104],"loop,":[105],"V3-glycan,":[107],"membrane-proximal":[109],"external":[110],"region":[111,115],"(MPER),":[112],"interface":[114],"fusion":[118],"peptide":[119],"so":[122],"called":[123],"\u2018silent":[124],"face\u2019.":[125],"Some":[126],"demonstrated":[132,154],"safely":[134],"suppress":[135],"viremia":[136],"delay":[138],"viral":[139,201],"rebound":[140],"interruption":[142],"HIV-1-infected":[148],"individuals.":[149],"Moreover,":[150],"prevent":[156],"infection":[157],"animal":[159],"models":[160],"prevention":[162,250,314],"studies":[163,296],"where":[164],"tested":[167],"their":[169,211,307],"effectivity":[170],"as":[171],"passive":[172],"immunization":[173],"humans":[175],"currently":[177],"ongoing.":[178],"Thus,":[179,254],"represent":[181],"promising":[183],"novel":[184,272,277],"approach":[185],"effective":[187],"immunotherapy":[189],"prevention.":[191],"However,":[192],"infusions":[193],"single":[195,243],"drive":[197],"emergence":[199],"escape":[202,260],"mutations":[203],"some":[205],"patients":[206],"harbor":[207],"pre-existing":[208],"proviral":[212],"or":[213,235,276,282],"circulating":[214],"quasispecies.":[216],"Furthermore,":[217],"recently":[219],"completed":[220],"proof-of-concept":[221],"Antibody":[222],"Mediated":[223],"Prevention":[224],"(AMP)":[225],"phase":[226],"2b":[227],"trials":[228],"showed":[229],"much":[231],"higher":[232],"bNAb":[233],"titers":[234],"broader":[239],"bNAbs,":[240,244],"especially":[241],"would":[245],"be":[246],"required":[247],"real-world":[252],"settings.":[253],"order":[256],"restrict":[258],"mechanisms":[261],"improved":[264],"antibody-mediated":[265],"prevention,":[267],"future":[268,308],"regimens":[269],"will":[270],"require":[271],"antibody":[274],"combinations":[275],"concepts":[278],"e.g.":[280],"bi-":[281],"trispecific":[283],"antibodies.":[284],"\\nIn":[286],"this":[287],"Research":[288],"Topic,":[289],"we":[290],"aim":[291],"bring":[293],"together":[294],"comprehensive":[298],"reviews":[299],"advance":[301],"field":[303],"clinical":[309],"use":[310],"treatment":[312],"HIV-1.":[316]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-12-31T00:00:00"}